Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Gene Target Technology Co. Ltd. has 1 pending office action in the Chemistry & Materials technology area. This pending matter is assigned to 1 distinct examiner and 1 distinct art unit. BEISNER, WILLIAM H is the busiest examiner, responsible for 1 pending office action. The company's current prosecution is focused on this single pending office action.
The involvement of 1 distinct art unit suggests that the application is being reviewed within a specific technical classification. This structure allows for a direct engagement with the specific requirements of the 1 distinct examiner involved. The concentration of 1 pending office action indicates that all active regulatory feedback is currently localized under a single point of review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEISNER, WILLIAM H | 1 | 61.9% | +29.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18512897 | AUTOMATED MOLECULAR OPERATING SYSTEM | BEISNER, WILLIAM H | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18512897 | AUTOMATED MOLECULAR OPERATING SYSTEM | BEISNER, WILLIAM H | 1799 | §112 | Non-Final OA | — | Pending | Nov 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGene Target Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
William H Beisner has the most, with 1 of Gene Target Technology Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
